MedPath
FDA Approval

Megestrol Acetate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Megestrol acetate(40 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Golden State Medical Supply, Inc.

Golden State Medical Supply, Inc.

603184490

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Megestrol Acetate

Product Details

NDC Product Code
60429-433
Application Number
ANDA072423
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 15, 2023
Code: TJ2M0FR8ESClass: ACTIBQuantity: 40 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath